REDUCED TREATMENT ESCALATION IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH DIABETES MELLITUS USING NEWER ANTI-DIABETIC MEDICATIONS: AN ANALYSIS FROM THE EPI-IIRN

Yuri Gorelik  1     Chagit Friss  2     Itamar Koren  2     Dima Shlon  1     Yiska Loewenberg Weisband  3     Amir Ben-Tov  4     Shira Greenfeld  4     Unknown Unknown  5     Eran Matz  6     Iris Dotan  7     Dan Turner  2     Haggai Bar-Yoseph  1    
1 Rambam Health Care Campus, Haifa, Israel
2 Shaare Zedek Medical Center, Jerusalem, Israel
3 Clalit Health Services, Tel-Aviv, Israel
4 Maccabi Health Services, Tel-Aviv, Israel
5 Meuhedet Health Services, Tel-Aviv, Israel
6 Leumit Health Services, Tel-Aviv, Israel
7 Rabin Medical Center, Petah Tikva, Israel

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing